Agios Pharmaceuticals, Inc. is a leading biopharmaceutical firm based in Cambridge, Massachusetts, focused on the discovery and development of transformative therapies for patients suffering from debilitating diseases linked to cellular metabolism. The company leverages its deep expertise in metabolic pathways to innovate novel treatments, particularly in oncology and rare genetic disorders, positioning itself at the forefront of precision medicine. With a robust pipeline and strategic collaborations, Agios is committed to advancing scientific understanding and improving patient outcomes through groundbreaking therapies.